DYSIS Medical provides a computer‑aided colposcopy system that quantifies acetowhitening changes during cervical examinations and generates a color‑coded DYSISmap™ to help healthcare professionals detect cervical lesions more efficiently. The solution combines a proprietary software platform with the DYSIS Colposcope, enabling objective lesion assessment and more confident patient management. It is designed for clinicians performing cervical screening to improve diagnostic accuracy and workflow.
Funding
£25.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Colposcopic examinations rely on visual assessment of acetowhitening, which can be subjective and lead to missed or inconsistent detection of cervical precancerous lesions. This variability hampers timely diagnosis and appropriate patient management during cervical screening.
Solution
DYSIS Medical offers a computer‑aided colposcopy system that integrates a proprietary DYSIS colposcope with advanced imaging software. During a standard exam, the device captures high‑resolution images and quantifies acetowhitening changes using dynamic spectral imaging algorithms. The software then generates a color‑coded DYSISmap™ that objectively highlights areas of abnormal tissue. Clinicians receive quantitative data and visual guidance in real time, enabling more consistent lesion identification and informed decisions about biopsies and treatment pathways.
Target Audience
Primary users are gynecologists, colposcopists, and women's health clinics that perform cervical cancer screening and need reliable, data‑driven lesion detection.
Features
- Integrated DYSIS colposcope with CE marking and FDA clearance for clinical use
- Dynamic spectral imaging that objectively measures acetowhitening intensity and duration
- Automated generation of a color‑coded DYSISmap™ to pinpoint suspicious regions
- Quantitative metrics displayed alongside live video to support biopsy targeting
- Compatibility with standard colposcopic workflow, requiring no additional procedural steps
- Secure data handling with encrypted storage and optional integration into electronic health records